Critical Care Update 2021

Table of Contents:
Section 1: Respiratory 1 Monitoring respiratory drive in spontaneous and mechanically ventilated patients 2 Use misuse and abuse of HFNC 3 Management of complex pleural effusion in ICU 4 ARDS phenotype: Clinical relevance 5 Long term consequences of ARDS its management 6 Diffuse Parenchymal lung disease 7 Patient self-inflicted lung injury: Clinical relevance 8 Role of P.01 in difficult weaning 9 Transpulmonary pressure guided ventilation: Where do we stand? 10 VILI prevention: is mechanical power targeted therapy the ultimate goal 11 Predicting microorganism in VAP: Is Surveillance culture the answer? 12 Effect of critical care illness on sleep Section 2: Extra corporeal life support 13 Infectious complications in patients on ECMO 14 CPR: To whom and when 15 ECMO in cardiogenic shock: When, and why and to whom? 16 Ventricular assess devices Section 3: Hemodynamics 17 Cardiovascular coupling (ventricular atrial): everyday relevance in critical care 18 Fluid resuscitation targets in sepsis: Should we stop monitoring MAP 19 Arterial elastance: The renewed interest 20 Perfusion index by pulse oximetry: Utility in ICU Section 4: Cardiovascular 21 ACLS 2020: What has changed 22 Refractory vasodilatory shock: What's new? 23 Optimizing diuresis in acute decompensated heart failure 24 Predicting intraoperative hypotension Section 5: Sepsis and Septic shock 25 Vitamins in sepsis B, C, D: Current status 26 Newer antibiotics for community acquired pneumonia 27 Recent advances in diagnosis and management of Candidemia 28 Cytokine blockade: double edge sword 29 Antifungal stewardship Section 6: Nutrition 30 Personalized feeding in septic patients 31 Risks of overfeeding in ICU 32 Protein versus calories: which is more important? 33 Muscle mass: bedside monitoring and relevance 34 Use of newer technology in ICU nutrition Section 7: Gastroenterology 35 Diagnosis and management of AKI in liver failure 36 Diarrhoea in immunocompromised patients 37 Cryptic infections in cirrhotic patients Section 8: USG and ECHO 38 Ultrasound assessment of weaning failure 39 POCUS in Sepsis 40 Role of ultrasound in de-resuscitation 41 Ultrasound guided ventilation 42 Lung ultrasound in COVID: Pearls and pitfalls Section 9: Renal and electrolytes 43 Drug induced AKI 44 Hyperviscocity syndromes 45 Timing of renal replacement therapy in ICU 46 Monitoring patients on CRRT 47 Urinary electrolyte measurement: When and why 48 Emphysematous pyelonephritis 49 Renal tubular acidosis in ICU: Are we missing it? Section 10: Neurocritical care 50 Imaging based ischemic stroke management: What should we know 51 Hypoxic ischemic encephalopathy 52 Antibiotic associated neurotoxicity 53 Autoimmune encephalitis 54 Antifibrinolytic therapy in TBI: What do we know? 55 Inhalation sedation in ICU: Is it worth all the effort? 56 Advanced directives in India: Ethical, legal and practical considerations 57 Optimizing availability and quality of cadaveric organs 58 Epidural analgesia in ICU, is it underused Section 11: COVID related ICU issues 59 Fungal pneumonia, COVID associated fungal 60 COVID breathlessness 61 Multi system cytokine inflammatory syndrome (MCIS) 62 Convalescent plasma therapy Section 12: Trauma/Perioperative/Toxicology/Burn 63 Perioperative delirium 64 Tranexamic acid: Current use in ICU 65 Optimising antimicrobial use in burns 66 Extracorporal Blood purification in poisoning and drug overdose Section 13: Quality/Ethics/Organisation/ICU research 67 Communication skills: Tricks of the trade 68 Use of artificial intelligence in ICU 69 Towards safer procedures in ICU 70 Temperature monitoring in the critically ill 71 Critical care pharmacist: An unmet need 72 Post ICU follow up clinic 73 Organ donation: Current guidelines 74 Care of elderly in ICU 75 Post traumatic stress disorder 76 Iatrogenic air embolism 77 Chlorhexadine oral hygiene in ICU: Is it safe? Section 14: Hematology/Oncology/Obstetrics /Pharmacology 78 Obstetric rapid response team 79 Iron substitution in ICU 80 Vasculitis in ICU 81 Life threatening complication of newer oncological therapies 82 Challenges in glucose monitoring in ICU 83 Detecting relative adrenal insufficiency and diabetes insipidus

About the Author :
Subhash Todi MD MRCP Director, Department of Critical Care, Advanced Medicare Research Institute, Kolkata, West Bengal, India Deepak Govil MD EDIC FICCM FCCM Director, Institute of Critical Care and Anesthesia, Medanta - The Medicity, Gurugram, Haryana, India Dhruva Chaudhry MD DNB DM Professor and Head, Department of Pulmonary and Critical Care Medicine, Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India Subhal Bhalchandra Dixit MD IDCCM FICCM FICP FCCM Consultant, Critical Care and Director, ICU, Department of Critical Care, Sanjeevan and MJM Hospitals, Pune, Maharashtra, India